the precise solution by sfm
In this blog you will regularly receive information about the product group nextaro®. The focus is on the reconstitution of lyophilized drugs, the problems and our solutions. In addition, special requirements of users and operators are also considered. We wish you much satisfaction and interest in exploring the nextaro® product group.
We are pleased to announce that our innovative medical product nextaro® has been successfully approved in Canada. This further milestone represents an important step in our international expansion and confirms the quality and recognition of our product.
Medical device approval in Canada requires…
In recent years, sustainability has become increasingly important in the medical industry. In particular, companies are increasingly focusing on the development and manufacture of sustainable medical products.
The current Covid-19 pandemic poses great challenges for the world. The situation should be controllable with global vaccination programs, but it will require an enormous logistic effort in terms of transport, storage and administration of the vaccines. How can freeze-dried vaccines simplify these…
Freeze-drying (lyophilization) is one of the most important pharmaceutical processes. It ensures the shelf life and storability of sensitive drugs. In which areas are freeze-dried active ingredients preferred and which medication groups are suitable for this process?
Freeze-drying has proven to be effective for preservation in the manufacture of sensitive biopharmaceutical products. The requirements of this complex process are high. Lyophilized active ingredients have several advantages. What are they, and what factors need to be considered during…
Top off your high quality application set with the device it deserves.
Please do not hesitate to contact us.
nextaro® is manufactured and distributed by:
sfm medical devices GmbH, Brückenstraße 5, 63607 Wächtersbach (Germany)
